Skip to content
Open access

Zinc Deficiency Exacerbates Cisplatin-Induced Acute Kidney Injury by Impairing Metabolic Adaptation and Antioxidant Defenses.

Oct 2026 · Chemico-Biological Interactions · Vol 440, pp. 112355 · 0 citations · 34 references
Medicine

TL;DR

It is suggested that zinc deficiency exacerbates Cis-AKI by weakening metabolic adaptation and antioxidant defenses, thereby promoting oxidative stress and apoptosis.

Abstract

Cisplatin-induced acute kidney injury (Cis-AKI) is a major limitation of chemotherapy and is largely driven by the inability of renal tubular epithelial cells to adapt to metabolic and oxidative stress. Zinc, an essential regulator of cellular stress responses, may influence this vulnerability, but its role in cisplatin nephrotoxicity remains unclear. Here, zinc-normal and zinc-deficient mice were subjected to Cis-AKI. Renal injury was evaluated by histology, serum creatinine (Scr), blood urea nitrogen (BUN), renal zinc levels, and NGAL expression. Transcriptomic analysis was performed to identify pathways altered by zinc deficiency, followed by validation of the AMPK/SIRT1/PGC-1α axis. Oxidative stress and apoptosis were assessed by Nrf2 signaling, antioxidant enzyme expression, SOD activity, MDA levels, TUNEL staining, and Bax/Bcl-2 expression. Zinc deficiency significantly aggravated Cis-AKI, as indicated by increased tubular damage, elevated Scr, BUN, and NGAL levels, and reduced renal zinc content. RNA sequencing revealed suppression of energy metabolism-related programs, accompanied by inhibition of the AMPK/SIRT1/PGC-1α axis, suggesting impaired metabolic adaptation. Zinc deficiency was also associated with reduced Nrf2 signaling, accompanied by decreased expression of antioxidant enzymes and total SOD activity, increased MDA accumulation, and enhanced tubular apoptosis. These findings suggest that zinc deficiency exacerbates Cis-AKI by weakening metabolic adaptation and antioxidant defenses, thereby promoting oxidative stress and apoptosis. Our study identifies zinc as a key regulator of tubular stress adaptation and suggests zinc homeostasis as a potential therapeutic target in cisplatin nephrotoxicity.

Read PDF

Similar papers

Open access Sep 2026

Echinacoside Alleviates Cisplatin-Induced Acute Kidney Injury by Regulating Bap1 to Inhibit Ferroptosis

Background/Objectives: Cisplatin-induced acute kidney injury (AKI) is a major adverse complication restricting cisplatin-based chemotherapy. Ferroptosis contributes substantially to proximal tubular epithelial injury during AKI. This work aimed to explore the renoprotective effect of echinacoside (ECH) and its underlyi...

Li-Jia Chen, Ming-Jie Zhang, M. Chi et al. · 0 citations
Open access Sep 2026

A novel Keap1-Nrf2 inhibitor 6K delays the progression of AKI-to-CKD by mitigating maladaptive repair

It is demonstrated that Nrf2 deficiency exacerbates AKI-CKD progression through redox imbalance and ferroptosis-mediated maladaptive repair, and targeting Keap1-Nrf2 with 6K protects against renal injury and fibrosis, highlighting its therapeutic potential for kidney diseases.

Yi-Ming Wang, Yi Sun, Ting Zhou et al. · 0 citations
Open access Sep 2026

Therapeutic Potential of Trilobatin in Cisplatin-Induced Kidney Injury: Targeting Ferroptosis and Inflammation

Cisplatin-induced acute kidney injury (CI-AKI) is a common and severe complication in cancer patients undergoing chemotherapy, which can progress to chronic kidney disease (CKD) and end-stage renal disease (ESRD). Ferroptosis and inflammation are critical pathological mechanisms underlying CI-AKI. Trilobatin (TLB),...

Yang Xiang, Die Zhang, Qiang-Fang Dai et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.